ABVC Biopharma Files Amendment on Accountant Change
Ticker: ABVC · Form: 8-K/A · Filed: Sep 12, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K/A |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: accountant-change, amendment
TL;DR
ABVC Bio just amended its 8-K filing to update its accountant, effective Sept 11, 2025.
AI Summary
ABVC Biopharma, Inc. filed an amendment (8-K/A) on September 12, 2025, to a previous report dated October 18, 2024. This amendment pertains to a change in the registrant's certifying accountant, with the change date being September 11, 2025. The company is incorporated in Nevada and headquartered in Fremont, California.
Why It Matters
Changes in a company's certifying accountant can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: low — This filing is an amendment to report a change in the certifying accountant, which is a routine administrative event.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- September 12, 2025 (date) — Filing Date of Amendment
- October 18, 2024 (date) — Date of Earliest Event Reported
- September 11, 2025 (date) — Date of Change in Certifying Accountant
- Nevada (jurisdiction) — State of Incorporation
- Fremont, CA (location) — Principal Business Address
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to amend a previous report to disclose a change in ABVC Biopharma, Inc.'s certifying accountant.
When was the amendment filed?
The amendment was filed on September 12, 2025.
What was the original report date being amended?
The original report date being amended was October 18, 2024.
When did the change in the certifying accountant become effective?
The change in the certifying accountant became effective on September 11, 2025.
Where is ABVC Biopharma, Inc. headquartered?
ABVC Biopharma, Inc. is headquartered at 44370 Old Warm Springs Blvd., Fremont, CA 94538.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-09-11 19:16:41
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ABVC The Nasdaq Stock Mar
Filing Documents
- ea0256995-8ka1_abvcbio.htm (8-K/A) — 23KB
- 0001213900-25-086952.txt ( ) — 185KB
- abvc-20241018.xsd (EX-101.SCH) — 3KB
- abvc-20241018_lab.xml (EX-101.LAB) — 33KB
- abvc-20241018_pre.xml (EX-101.PRE) — 22KB
- ea0256995-8ka1_abvcbio_htm.xml (XML) — 4KB
01 Changes in Registrant's
Item 4.01 Changes in Registrant's Certifying Accountant. We filed a Current Report on Form 8-K on October 18, 2024, to disclose that on October 10, 2024, WWC, P.C. ("WWC"), serving as the Company's independent registered public accounting firm, agreed not to renew its engagement with the Company (the "Original 8K"). As disclosed in the Original 8K, although we provided WWC with a copy of the Original 8K and requested WWC to furnish us with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made therein, WWC had not yet agreed or declined to provide such a letter. As of the date hereof, WWC has refused to provide us with such a letter. 1 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABVC BioPharma, Inc. September 12, 2025 By: /s/ Uttam Patil Uttam Patil Chief Executive Officer 2